J. Anthony Ware, M.D.

J. Anthony Ware, M.D., is an affiliate faculty member of the Department of Internal Medicine and serves as an advisor to Texas Health Catalyst. He is a member of the board of directors for AnaptysBio, a publicly traded biotech, and VasoRx, a privately held biotech, both in San Diego.

In 2018, Ware retired from Eli Lilly, where he was the senior vice president of product development. During his Lilly career, Ware was responsible for medicine development in several therapeutic areas, including cardiovascular disease, acute care, diabetes, men’s health, neuroscience, pain therapeutics, immunological diseases and bone health. Previously he served on the boards of BioCritica, a biotech focused on critical care, and BioCrossroads, a nonprofit dedicated to advancing Indiana’s strengths in biotechnology.

Before joining Lilly, Ware was the Sidney L. and Miriam K. Olsen chair of cardiology at The Albert Einstein College of Medicine in New York, where he was also professor of molecular pharmacology, with tenure. He was also the inaugural chief of the Unified Cardiovascular Division at Montefiore Medical Center, also in New York. Before Einstein, Ware was appointed to the faculty of Harvard Medical School in Boston, where he served as a senior physician and director of the coronary care unit at Beth Israel Hospital, also in Boston.

He is the author of over 150 peer-reviewed articles and 32 book chapters.